Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: Potential importance of dialysate quality

Nephrology Dialysis Transplantation

Volumn 17, Issue 6, 2002, Pages 1045-1049

  Gerdemann, Andrea ^a   Wagner, Zoltan ^a   Solf, Andreas ^b   Bahner, Udo ^c   Heidland, August ^c   Vienken, Jörg ^d   Schinzel, Reinhard ^a,e  

^a Biozentrum   (Germany)

^b Nephrologisches Zentrum Niedersachsen   (Germany)

^c Kuratorium für Dialyse und Nierentransplantation   (Germany)

^d FRESENIUS MEDICAL CARE   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Advanced glycation end products; End stage renal disease; Haemodiafiltration; Haemodialysis; Haemofiltration

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DIALYSIS FLUID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIALYSATE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW RATE; FLUORESCENCE SPECTROSCOPY; GEL FILTRATION CHROMATOGRAPHY; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STANDARD; WATER QUALITY; BLOOD; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; HEMODIAFILTRATION; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SPECTROFLUOROMETRY;

AGED; CROSS-SECTIONAL STUDIES; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RENAL DIALYSIS; SPECTROMETRY, FLUORESCENCE;

EID: 0035991971     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.6.1045     Document Type: Article

References (17)

1. Serum advanced glycosylation end products: A new class of uremic toxins?
2. Toxicity of uraemia-does it come of AGE?
3. Advanced glycation endproducts in diabetes and ageing
4. Glycation and advanced glycation endproducts
5. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
6. The pathogenesis and consequences of AGE formation in uremia and its treatment
7. AGEs: A nephrologist's perspective
8. Relevance of oxidative and carbonyl stress to long-term uremic complications
9. The quality of dialysate: An integrated approach
10. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA
11. N(carboxymethyl)lysine levels in type 2 diabetic patients: Role of renal function
12. No change in corrected β2-microglobulin concentrations after cuprophan hemodialysis
13. Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy
14. Low-molecular but not high-molecular AGEs are removed by high-flux dialysis
15. Advanced glycated end-products (AGE) during haemodialysis treatment: Discrepant results with different methodologies reflecting the heterogeneity of AGE compounds
16. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of 'carbonyl stress'
17. Ultrafiltration and convective-based dialysis modalities: New trends and applications for renal replacement therapy in ESRD patients